|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 549 active entries
48 Lorong 21 Geylang #03-01 Greatland Building
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Lynk Biotechnologies Pte Ltd is a fast expanding Singapore-based pharmaceutical company dedicated to the application of revolutionary technologies for the design and development of innovative healthcare and cosmetic products and services. Spun off from National University of Singapore (NUS) in 2000 by Associate Professor Lee Chee Wee from the Yong Loo Lin School of Medicine, Lynk Biotech has since established two subsidiary companies and a strong portfolio of platform technologies, products and services.
MediLynk Pte Ltd is a wholly-owned subsidiary of Lynk Biotech. Founded in 2004, it has wide-ranging commercial responsibilities, including international business development, sales, marketing and distribution.
Lynk Biotech is also parent company of DynaLynk Pharma Pte Ltd, a state-of-the-art manufacturing facility that has pharmaceutical GMP (Good Manufacturing Practice) certification accredited by the Health Sciences Authority of Singapore (HSA). Besides the large scale manufacturing capabilities of DynaLynk Pharma, Lynk Biotech also possesses smaller scale pilot batch manufacturing capabilities. These manufacturing capabilities are complemented by an in-house quality testing laboratory.
Last update of this entry: March 16, 2011